| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 10/13/2004 | EP1177217B1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules |
| 10/13/2004 | EP1131340B1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 10/13/2004 | EP1107746B1 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | EP0986389B1 Novel process |
| 10/13/2004 | EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 10/13/2004 | CN1537115A C2,5'-disubstituted and N6, C2, 5' trisubstituted adenosine derivatives and their different uses |
| 10/13/2004 | CN1537114A Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor |
| 10/13/2004 | CN1537112A Pyrimidine compound |
| 10/13/2004 | CN1537109A Novel modifications of aminobutantriol salt of r-thioctic acid and method for producing the same |
| 10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 10/13/2004 | CN1537098A Crystalline forms VI and VII of atorvastatin calcium |
| 10/13/2004 | CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 10/13/2004 | CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor |
| 10/13/2004 | CN1537010A Drugs for ameliorating postcibal hyperglycaemia |
| 10/13/2004 | CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method |
| 10/13/2004 | CN1537008A Pharmaceutical combination comprising either (S)-20ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl] propanoic acid |
| 10/13/2004 | CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases |
| 10/13/2004 | CN1537002A Novel theterocyclic analogs of diphenylethylene compounds |
| 10/13/2004 | CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 10/13/2004 | CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
| 10/13/2004 | CN1536999A Crystalline forms |
| 10/13/2004 | CN1536996A (-)-olivil as antioxidant |
| 10/13/2004 | CN1536994A Hypoglycemic agent |
| 10/13/2004 | CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 10/13/2004 | CN1536989A Oral compositions comprising host-respones modulating agent for promoting whole body health |
| 10/13/2004 | CN1536967A Nutritional composition preventing bacterial overgrowth |
| 10/13/2004 | CN1536075A Method for inducing bone marrow mesenchymal stem cells to differentiate into insulin-like cells |
| 10/13/2004 | CN1535957A New isoquinoline compounds, their preparation method and medicine composition contaning them |
| 10/13/2004 | CN1535717A Chinese medicine clove and application of its extract in preparation of medicine for reducing weight |
| 10/13/2004 | CN1535705A Medicinal components composition for preventing dehydration reaction |
| 10/13/2004 | CN1535681A Application of dipeptide base peptidase IV effector for reducing blood sugar level of mammal |
| 10/13/2004 | CN1535622A Processing process for making beverage and food by using duck wheat as raw material |
| 10/13/2004 | CN1535605A Drink and food |
| 10/13/2004 | CN1170851C Fatty diacylamino acid insulin as oral medicine for treating diabetes and its synthesizing process |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170822C Imidazole compounds and medicinal use thereof |
| 10/13/2004 | CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 10/13/2004 | CN1170567C Ribes Janczewskii plant fruit extractive and its prepn |
| 10/13/2004 | CN1170560C Health care medical tea and production method thereof |
| 10/13/2004 | CN1170554C Help producing saliva and slaking thirst traditional Chinese medicine powder |
| 10/13/2004 | CN1170551C Hypoglycemic, antihypertensive and antisenility powder for dietotherapy and its preparing process |
| 10/13/2004 | CN1170549C Process for preparing 'Qianjin' capsule to treat genopathy |
| 10/13/2004 | CN1170535C Use of medicine for treatment of migraikne by the administration of alpha-lipoic acid |
| 10/13/2004 | CN1170534C Pharmaceutical compositions containing lipase inhibitors |
| 10/13/2004 | CN1170531C Preparation and application of seleno-methinoine chrome yellow urea as hypoglycemic |
| 10/12/2004 | US6803480 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | CA2100817C Heteroacetic acid derivatives |
| 10/07/2004 | WO2004085452A1 Compound having affinity with calcified tissue |
| 10/07/2004 | WO2004085448A2 Unsaturated phosphinyl-phosphonate phosphate transport inhibitors |
| 10/07/2004 | WO2004085409A2 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof |
| 10/07/2004 | WO2004085403A1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 10/07/2004 | WO2004085391A1 Process for the synthesis of amorphous atorvastatin calcium |
| 10/07/2004 | WO2004085389A1 Lipid metabolism improving agent |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084944A1 Novel blood sugar regulating agent and method of screening the same |
| 10/07/2004 | WO2004084930A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
| 10/07/2004 | WO2004084906A1 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 10/07/2004 | WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | WO2004084891A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 10/07/2004 | WO2004084885A1 Compositions for the improvement of obesity |
| 10/07/2004 | WO2004075823A3 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 10/07/2004 | WO2004045518A3 Open chain prolyl urea-related modulators of androgen receptor function |
| 10/07/2004 | WO2004012659A3 Nitrosated proton pump inhibitors, compositions and methods of use |
| 10/07/2004 | WO2003099195A3 Immunomodulatory compounds and methods of use thereof |
| 10/07/2004 | WO2003076427A8 Quinazoline compounds useful in therapy |
| 10/07/2004 | WO2003068757A9 Novel pyridin- and pyrimidin-derivatives |
| 10/07/2004 | WO2003068748A9 Novel pyridine- and quinoline-derivatives |
| 10/07/2004 | WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 10/07/2004 | WO2002092000A3 Hbm variants that modulate bone mass and lipid levels |
| 10/07/2004 | WO2002088317A3 Fusion molecules and methods for treatment of immune diseases |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198949 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 10/07/2004 | US20040198832 Compositions and methods for treating amyloidosis |
| 10/07/2004 | US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects |
| 10/07/2004 | US20040198811 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198810 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198809 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198799 Methods of increasing endogenous testosterone levels |
| 10/07/2004 | US20040198791 Fused imidazole derivative |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198776 Methods for increasing leptin levels using nicotinic acid compounds |
| 10/07/2004 | US20040198766 Chemical compounds |
| 10/07/2004 | US20040198740 Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 |
| 10/07/2004 | US20040198738 Preventives or remedies for diseaes caused by enos expression |
| 10/07/2004 | US20040198737 Azaindoles |
| 10/07/2004 | US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 10/07/2004 | US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents |
| 10/07/2004 | US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders |
| 10/07/2004 | US20040198725 A bi-heterocyclic compound e.g 3-methoxyphenyl)-{6-Morpholin-4-yl-2-[2-(pyridin-2-yloxy)-ethoxy]-9H-purin-8-yl}-amine or other derivatives useful for treating an interleukin-12 overproduction-related disorder such as rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis or diabetes |
| 10/07/2004 | US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 10/07/2004 | US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders |
| 10/07/2004 | US20040198700 Administering to a patient an azetidinone compound containing at least 3 phenyl rings fo rprevention of a vascular condition, diabetes, obesity, stroke, lowering a concentration of a sterol or stanol in plasma of a mammal, preventing demyelination or treating Alzheimer's disease |
| 10/07/2004 | US20040198699 Composition and method for the treatment of dysglucaemia |
| 10/07/2004 | US20040198694 Formulation to treat or prevent parasitic infection |
| 10/07/2004 | US20040198673 Composition for epigallocatechin gallate |
| 10/07/2004 | US20040198668 synergistic admnistration of a weight-loss promoting anticonvulsant and a norepinephrine or dopamine agonist; hypotensive, antidiabetic, anticholesterol agents |